Gheorghe Doros, PhD
Professor
Boston University School of Public Health
Dept of Biostatistics

PhD, Yale University
MA, Yale University
MS, University of Bucharest



Gheorghe Doros is Professor of Biostatistics and director of the Biostatistics Consulting Group. He received his PhD in statistics from Yale University and joined BUSPH’s Department of Biostatistics in 2006 after spending two years at Eli Lilly, as a member of that company's Drug Discovery and Toxicology department. Professor Doros’s interests focus on Clinical Trials, Bayesian Statistics, asymptotic statistics, testing, and computational statistics. He is involved in projects that evaluate the effects of physical and emotional stresses of caregiving on physical and psychological health. He also serves as a statistical consultant to Boston Medical Center’s Amyloid Center and as biostatistician for the Boston University Clinical Research Training (CREST) project. At BUSPH, he teaches the course in Computational Statistics and Generalized Linear Models.

Boston Medical Center




Personnel Agreement for Research Services of Gheorghe Doros
05/01/2016 - 08/31/2018 (PI)
VA Boston Healthcare System

Gheorghe Doros, PhD (faculty): Statistical research in clinical trials (Harvard Clinical Research Institute)
09/01/2016 - 08/31/2017 (PI)
Harvard Clinical Research Institute

Personnel Agreement for Research Services of Gheorghe Doros
06/01/2012 - 02/28/2016 (PI)
VA Boston Healthcare System

Personnel agreement for research services of Gheorghe Doros
07/01/2012 - 05/31/2013 (PI)
VA Boston Healthcare System

Personnel Agreement for Research Services of Gheorghe Doros
08/01/2009 - 03/31/2012 (PI)
VA Boston Healthcare System

Personnel Agreement for Research Services of Gheorghe Doros
06/01/2008 - 03/31/2012 (PI)
VA Boston Healthcare System

Lower Extremity Muscle Power and Function in the Elderly
06/15/2005 - 05/31/2010 (PI)
Tufts University NIH NIA




Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Browning S, Quillen K, Sloan JM, Doros G, Sarosiek S, Sanchorawala V. Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation. Blood. 2017 Jul 11.View Related Profiles. PMID: 28698204.
  2. Tan TW, Eslami M, Rybin D, Doros G, Zhang WW, Farber A. Outcomes of endovascular and open surgical repair of ruptured abdominal aortic aneurysms in elderly patients. J Vasc Surg. 2017 Jul; 66(1):64-70.View Related Profiles. PMID: 28216354; DOI: 10.1016/j.jvs.2016.10.119;.
  3. Traish A, Haider KS, Doros G, Haider A. Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction. Horm Mol Biol Clin Investig. 2017 Jun 21; 30(3).View Related Profiles. PMID: 28632494.
  4. Inagaki E, Farber A, Kalish J, Siracuse JJ, Zhu C, Rybin DV, Doros G, Eslami MH. Role of language discordance in complication and readmission rate after infrainguinal bypass. J Vasc Surg. 2017 Jun 16.View Related Profiles. PMID: 28625669.
  5. Salzler GG, Farber A, Rybin DV, Doros G, Siracuse JJ, Eslami MH. The association of Carotid Revascularization Endarterectomy versus Stent Trial (CREST) and Centers for Medicare and Medicaid Services Carotid Guideline Publication on utilization and outcomes of carotid stenting among "high-risk" patients. J Vasc Surg. 2017 Jul; 66(1):104-111.e1.View Related Profiles. PMID: 28502543.
  6. Katz DF, Maddox TM, Turakhia M, Gehi A, O''Brien EC, Lubitz SA, Turchin A, Doros G, Lei L, Varosy P, Marzec L, Hsu JC. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Assessment: Analysis From the National Cardiovascular Data Registry''s Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry. Circ Cardiovasc Qual Outcomes. 2017 May; 10(5). PMID: 28506981.
  7. McIntosh AI, Doros G, Jones-López EC, Gaeddert M, Jenkins HE, Marques-Rodrigues P, Ellner JJ, Dietze R, White LF. Extensions to Bayesian generalized linear mixed effects models for household tuberculosis transmission. Stat Med. 2017 Jul 20; 36(16):2522-2532.View Related Profiles. PMID: 28370491; DOI: 10.1002/sim.7303;.
  8. Feldstein DA, Hess R, McGinn T, Mishuris RG, McCullagh L, Smith PD, Flynn M, Palmisano J, Doros G, Mann D. Design and implementation of electronic health record integrated clinical prediction rules (iCPR): a randomized trial in diverse primary care settings. Implement Sci. 2017 Mar 14; 12(1):37.View Related Profiles. PMID: 28292304; DOI: 10.1186/s13012-017-0567-y;.
  9. Casillas-Berumen S, Sadri L, Farber A, Eslami MH, Kalish JA, Rybin D, Doros G, Siracuse JJ. Morbidity and mortality after emergency lower extremity embolectomy. J Vasc Surg. 2017 Mar; 65(3):754-759.View Related Profiles. PMID: 28236918; DOI: 10.1016/j.jvs.2016.08.116;.
  10. Peacock MR, Farber A, Eslami MH, Kalish JA, Rybin D, Doros G, Shah NK, Siracuse JJ. Hypoalbuminemia Predicts Perioperative Morbidity and Mortality after Infrainguinal Lower Extremity Bypass for Critical Limb Ischemia. Ann Vasc Surg. 2017 May; 41:169-175.e4.View Related Profiles. PMID: 28242402; DOI: 10.1016/j.avsg.2016.08.043;.
Showing 10 of 151 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 151 publications over 14 distinct years, with a maximum of 30 publications in 2015

YearPublications
20041
20051
20062
20077
20082
200910
20109
201114
20128
201315
201420
201530
201617
201715
Contact for Mentoring:


801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


Doros's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department